Chronic inflammation: A new therapeutic target for post-traumatic stress disorder?

The Lancet Psychiatry

Volumn 2, Issue 11, 2015, Pages 954-955

  Michopoulos, Vasiliki ^a,b   Jovanovic, Tanja ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ALCOHOL CONSUMPTION; CARDIOVASCULAR DISEASE; CHRONIC INFLAMMATION; DEPRESSION; HUMAN; INFECTION; LUNG DISEASE; META ANALYSIS (TOPIC); NOTE; OBESITY; POSTTRAUMATIC STRESS DISORDER; SMOKING; INFLAMMATION; STRESS DISORDERS, POST-TRAUMATIC;

HUMANS; INFLAMMATION; STRESS DISORDERS, POST-TRAUMATIC;

EID: 84952032097     PISSN: 22150366     EISSN: 22150374     Source Type: Journal    
DOI: 10.1016/S2215-0366(15)00355-7     Document Type: Note

References (9)

1. Passos IC, Vasconcelos-Moreno MP, Costa LG, et al. Inflammatory markers in post-traumatic stress disorder: a systematic review, meta-analysis, and meta-regression. Lancet Psychiatry 2015, 2:1002-1012.
2. Michopoulos V, Norrholm SD, Jovanovic T Diagnostic biomarkers for posttraumatic stress disorder: promising horizons from translational neuroscience research. Biol Psychiatry 2015, 78:344-353.
3. Cuthbert BN Translating intermediate phenotypes to psychopathology: The NIMH Research Domain Criteria. Psychophysiology 2014, 51:1205-1206.
4. Dowlati Y, Herrmann N, Swardfager W, et al. A meta-analysis of cytokines in major depression. Biol Psychiatry 2010, 67:446-457.
5. Tursich M, Neufeld RW, Frewen PA, et al. Association of trauma exposure with proinflammatory activity: a transdiagnostic meta-analysis. Transl Psychiatry 2014, 4:e413.
6. Michopoulos V, Rothbaum AO, Jovanovic T, et al. Association of CRP genetic variation and CRP level with elevated PTSD symptoms and physiological responses in a civilian population with high levels of trauma. Am J Psychiatry 2015, 172:353-362.
7. Eraly SA, Nievergelt CM, Maihofer AX, et al. Assessment of plasma C-reactive protein as a biomarker of posttraumatic stress disorder risk. JAMA Psychiatry 2014, 71:423-431.
8. Segman RH, Stein MB C-reactive protein: a stress diathesis marker at the crossroads of maladaptive behavioral and cardiometabolic sequelae. Am J Psychiatry 2015, 172:307-309.
9. Raison CL, Rutherford RE, Woolwine BJ, et al. A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers. JAMA Psychiatry 2013, 70:31-41.